Yale Study Connects Long COVID with Autoantibodies
Our researchers are not only making an impact in blood cancer research, they’re also making important discoveries in the fight against Covid. Immunologists Akiko Iwasaki, PhD, and Gabrielle’s Angels grantee Aaron Ring, MD, PhD, have identified autoantibodies in patients who have had COVID-19. Autoantibodies are antibodies (proteins produced in response to a pathogen) that mistakenly target and react with a person’s own tissues or organs. The Yale team has identified these autoantibodies in other systems of the body, which may help to explain why some patients develop specific conditions from the virus, including post-COVID syndrome. More research is needed to determine if long Covid patients have these autoantibodies, which may be a potential therapeutic target for COVID-19. Read the full article here.